Catalyst Wire Dossier Catalyst Wire Dossier

AMPICILLIN AND SULBACTAM

AMPICILLIN SODIUM AND SULBACTAM SODIUM · Eugia US LLC
Drug timelines are a Plus or Pro feature.

45 regulatory and trial events tracked for AMPICILLIN AND SULBACTAM, covering 2006-07-25 to 2026-03-03. Get the full timeline:

Most recent: FDA Approved: AMPICILLIN AND SULBACTAM — Supplemental Application (Avenacy, LLC)

See pricing